Clinical Trial Update: The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

This Phase 2 study reports on the short-term safety and efficacy of inhaled L-arginine in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled L-arginine (L-arginine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED